SERPINE I-844 and-675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population

被引:6
作者
Xu, Xia [1 ]
Wang, Hongchao [2 ]
Li, Haijun [1 ]
Cui, Xiaopei [1 ]
Zhang, Hongyu [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Dept Pulm Med, Jinan, Peoples R China
关键词
Chronic obstructive pulmonary disease; plasminogen activator inhibitor-I; single-nucleotide polymorphism; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PROMOTER POLYMORPHISM; 4G/5G POLYMORPHISM; PAI-1; ASSOCIATION; EXPRESSION; COMPONENTS; FIBROSIS; SYSTEM; COPD;
D O I
10.1177/0300060516664270
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate the association between serpin family E member I (SERPINE I) -844 A/G and -675 4G/5G polymorphisms and chronic obstructive pulmonary disease (COPD) in a Chinese Han population. Method: SERPINE -844 A/G and -675 4G/5G polymorphisms were assessed by polymerase chain reaction-restriction fragment length polymorphism sequencing of genomic DNA from patients with COPD and healthy smoking controls. Results: Out of 140 patients with COPD and 100 controls, all SERPINE/ -844 and -675 polymorphisms were in Hardy-Weinberg equilibrium. Differences in SERPINE/-675 4G and 5G allele frequencies were statistically significant between the COPD and control groups (odds ratio [OR] 1.45, 95% confidence interval [CI] 1.00, 2.09), but there was no significant between -group difference in SERPINE I -844 A and G allele frequencies. The SERPINE I -675 4G/4G genotype was associated with COPD (OR 1.87, 95% CI 1.06, 3.32 [binary logistic regression]). Haplotype analysis showed that COPD was associated with SERPINE I -844G/4G (OR 2.1 I, 95% CI 1.32, 3.38) and SERPINE I -844G/5G (OR 0.66, 95% CI 0.45, 0.95). Conclusion: The SERPINE I -675 polymorphism, but not SERPINE I -844 polymorphism, was associated with susceptibility to COPD in a Chinese Han population.
引用
收藏
页码:1292 / 1301
页数:10
相关论文
共 27 条
[11]   A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia [J].
Kim, KK ;
Flaherty, KR ;
Long, Q ;
Hattori, N ;
Sisson, TH ;
Colby, TV ;
Travis, WD ;
Martinez, FJ ;
Murray, S ;
Simon, RH .
MOLECULAR MEDICINE, 2003, 9 (1-2) :52-56
[12]  
Kowal K, 2008, J INVEST ALLERG CLIN, V18, P284
[13]   Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1 [J].
Li Xin-xia ;
Li Ning ;
Ban Cheng-jun ;
Zhu Min ;
Xiao Bai ;
Dai Hua-ping .
CHINESE MEDICAL JOURNAL, 2011, 124 (13) :1923-1927
[14]   IL 13 PROMOTER (-1055) POLYMORPHISMS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN TAIWANESE [J].
Liu, Shih-Feng ;
Chen, Yung-Che ;
Wang, Chin-Chou ;
Fang, Wen-Feng ;
Chin, Chien-Hung ;
Su, Mao-Chang ;
Lin, Meng-Chih .
EXPERIMENTAL LUNG RESEARCH, 2009, 35 (10) :807-816
[15]   The genetics of chronic obstructive pulmonary disease [J].
Lomas, DA ;
Silverman, EK .
RESPIRATORY RESEARCH, 2001, 2 (01) :20-26
[16]   Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation [J].
Ma, Z. ;
Paek, D. ;
Oh, C. K. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (08) :1136-1144
[17]   Binding of upstream stimulatory factor 1 to the E-Box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells [J].
Ma, Zhongcai ;
Jhun, BongSook ;
Jung, Sandy Y. ;
Oh, Chad K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (04) :1006-1012
[18]   Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters - The HIFMECH study [J].
Morange, P. E. ;
Saut, N. ;
Alessi, M. C. ;
Yudkin, J. S. ;
Margaglione, M. ;
Di Minno, G. ;
Hamsten, A. ;
Humphries, S. E. ;
Tregouet, D. A. ;
Juhan-Vague, I. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) :2250-2257
[19]   The-675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis [J].
Nie, Wei ;
Li, Bing ;
Xiu, Qing-yu .
PLOS ONE, 2012, 7 (03)
[20]   Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia [J].
Renckens, Rosemarijn ;
Roelofs, Joris J. T. H. ;
Bonta, Peter I. ;
Florquin, Sandrine ;
de Vries, Carlie J. M. ;
Levi, Marcel ;
Carmeliet, Peter ;
van't Veer, Cornelis ;
van der Poll, Tom .
BLOOD, 2007, 109 (04) :1593-1601